Drug Type Non-recombinant coagulation factor |
Synonyms- |
Target |
Action modulators |
Mechanism fibrin modulators(Fibrin modulators), Fibrinogen replacements(Fibrinogen replacements) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date China (01 Jan 1997), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Afibrinogenemia | China | 01 Jan 1997 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acquired fibrinogen deficiency | IND Approval | China | 28 Sep 2025 | |
Congenital fibrinogen deficiency | IND Approval | China | 28 Sep 2025 |